This blog post takes a deep dive into what this means for patients, separating fact from fear, and helping you understand how to balance the benefits and risks of GLP-1 therapy
Research also has shown that a significant percentage of people stop taking the medications after one year due to side effects, Carroll noted
60% know someone who wants to take a GLP-1 but cannot afford it
even though social media is not necessarily representative, a large collection of posts may reflect additional concerns. Upcoming webinars The science of HMOs A novonesis webinar featuring new clinical findings and ESPGHAN highlights Novonesis From boosters to companions: GLP-1 in Food, Beverages and Supplements Rousselot Top Nutrition Trends 2027 Nutrition Insight
Understanding Ozempic and High Blood Pressure Ozempic contains the active ingredient semaglutide, a GLP-1 receptor agonist, along with inactive ingredients such as disodium phosphate dihydrate, sodium chloride, and water for injection, which help stabilize the medication for safe use
Can You Switch Between GLP-1 Medications